Ignite Creation Date:
2025-12-25 @ 4:01 AM
Ignite Modification Date:
2025-12-26 @ 2:54 AM
Study NCT ID:
NCT00996502
Status:
TERMINATED
Last Update Posted:
2019-03-27
First Post:
2009-10-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer
Sponsor:
Columbia University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AAAB8399
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |